Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua H Abasszade

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
World Journal of Gastrointestinal Pharmacology and Therapeutics|July 24, 2023
Hepatitis C virus treatment with glecaprevir and pibrentasvir in patients co-prescribed carbamazepine: Three case reportsMichael Braude, Dilip T Ratnam, Louise Marsh, et al.
Cureus|November 15, 2024
Isolated Lower Limb Vasculitis Following SARS-CoV-2 Infection: A Case ReportAlexander Mitropoulos, Maanasa Bandla, Joshua H Abasszade, et al.
BMJ Open|October 23, 2021
Observational study of the relative efficacy of insulin-glucose treatment for hyperkalaemia in patients with liver cirrhosisAndy K H Lim, Ljiljana Crnobrnja, Manogna Metlapalli, et al.
Advanced Drug Delivery Reviews|April 14, 2022
Altered peripheral factors affecting the absorption, distribution, metabolism, and excretion of oral medicines in Alzheimer's diseaseElka S Waller, Ben J Yardeny, Wan Yun Fong, et al.
Cancers|June 19, 2024
Different Patterns of Care and Survival Outcomes in Transplant-Centre Managed Patients with Early-Stage HCC: Real-World Data from an Australian Multi-Centre Cohort StudyJonathan Abdelmalak, Simone I Strasser, Natalie L Ngu, et al.
Cancers|December 23, 2023
Improved Survival Outcomes with Surgical Resection Compared to Ablative Therapy in Early-Stage HCC: A Large, Real-World, Propensity-Matched, Multi-Centre, Australian Cohort StudyJonathan Abdelmalak, Simone I Strasser, Natalie Ngu, et al.
Cancers|September 14, 2024
Initial Trans-Arterial Chemo-Embolisation (TACE) Is Associated with Similar Survival Outcomes as Compared to Upfront Percutaneous Ablation Allowing for Follow-Up Treatment in Those with Single Hepatocellular Carcinoma (HCC) ≤ 3 cm: Results of a Real-World Propensity-Matched Multi-Centre Australian Cohort StudyJonathan Abdelmalak, Simone I Strasser, Natalie L Ngu, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
World Journal of Gastrointestinal Pharmacology and Therapeutics|July 24, 2023
Hepatitis C virus treatment with glecaprevir and pibrentasvir in patients co-prescribed carbamazepine: Three case reportsMichael Braude, Dilip T Ratnam, Louise Marsh, et al.
Cureus|November 15, 2024
Isolated Lower Limb Vasculitis Following SARS-CoV-2 Infection: A Case ReportAlexander Mitropoulos, Maanasa Bandla, Joshua H Abasszade, et al.
BMJ Open|October 23, 2021
Observational study of the relative efficacy of insulin-glucose treatment for hyperkalaemia in patients with liver cirrhosisAndy K H Lim, Ljiljana Crnobrnja, Manogna Metlapalli, et al.
Advanced Drug Delivery Reviews|April 14, 2022
Altered peripheral factors affecting the absorption, distribution, metabolism, and excretion of oral medicines in Alzheimer's diseaseElka S Waller, Ben J Yardeny, Wan Yun Fong, et al.
Cancers|June 19, 2024
Different Patterns of Care and Survival Outcomes in Transplant-Centre Managed Patients with Early-Stage HCC: Real-World Data from an Australian Multi-Centre Cohort StudyJonathan Abdelmalak, Simone I Strasser, Natalie L Ngu, et al.
Cancers|December 23, 2023
Improved Survival Outcomes with Surgical Resection Compared to Ablative Therapy in Early-Stage HCC: A Large, Real-World, Propensity-Matched, Multi-Centre, Australian Cohort StudyJonathan Abdelmalak, Simone I Strasser, Natalie Ngu, et al.
Cancers|September 14, 2024
Initial Trans-Arterial Chemo-Embolisation (TACE) Is Associated with Similar Survival Outcomes as Compared to Upfront Percutaneous Ablation Allowing for Follow-Up Treatment in Those with Single Hepatocellular Carcinoma (HCC) ≤ 3 cm: Results of a Real-World Propensity-Matched Multi-Centre Australian Cohort StudyJonathan Abdelmalak, Simone I Strasser, Natalie L Ngu, et al.
Pageof 1